DGAP-News: Eckert & Ziegler Awarded for Excellent Training Quality
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous
Eckert & Ziegler Awarded for Excellent Training Quality
20.03.2019 / 13:29
The issuer is solely responsible for the content of this announcement.
Berlin, 20 March 2019. Eckert & Ziegler has been awarded for "excellent training quality" by the Berlin Chamber of Industry and Commerce (IHK). The award recognizes the quality of training of young employees.
The Chamber of Industry and Commerce (IHK) evaluated the training at Eckert & Ziegler based on more than 40 criteria. Amongst other things, the general conditions, the implementation and the supervision of the training were evaluated. The auditors were able to get a personal impression of the training conditions during an on-site visit. Especially convincing were the onboarding processes, the individual operation plans adapted to the training framework plan, and the team-building measures. In addition, Eckert & Ziegler impressed with the fact that trainees are involved at an early stage in independent projects which promotes social skills.
"We are very pleased about this award. The best proof that the education at Eckert & Ziegler is of a high standard are our great trainees", explained Dr Harald Hasselmann, member of the Executive Board of Eckert & Ziegler AG. "The IHK certification shows that we are on the right track. It will make Eckert & Ziegler an even more attractive company for school leavers. Significant for the very good training at our company is the large number of former trainees who support us as specialists in various departments of our company. The hiring rate is around 70%."
Since 2005, Eckert & Ziegler has been regularly training industrial clerks and IT specialists for system integration. The application deadline for a training position at Eckert & Ziegler is mid-March every year. The apprenticeship begins in September of the same year.
Click here for photo material: https://www.ezag.com/award-ceremony-2019
About Eckert & Ziegler.
The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The Group is an international leader in some of its fields. The company employs around 800 people at 20 locations worldwide, 240 of them are working at the headquarters in Berlin-Buch. Eckert & Ziegler has been listed on the stock exchange since 1999 and is listed in the Prime Standard of the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).
Contributing to saving lives.
Your contact for questions:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com
20.03.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
Eckert & Ziegler Strahlen- und Medizintechnik AG |
|
Robert-Rössle-Str.10 |
|
13125 Berlin |
|
Germany |
Phone: |
49 30 941084-138 |
Fax: |
49 30 941084-112 |
E-mail: |
[email protected] |
Internet: |
www.ezag.de |
ISIN: |
DE0005659700 |
WKN: |
565970 |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
|
End of News |
DGAP News Service |
789761 20.03.2019
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
138,63 |
168,71 |
178,49 |
176,14 |
180,44 |
222,26 |
246,09 |
EBITDA1,2 |
26,62 |
32,14 |
43,13 |
44,64 |
57,04 |
55,52 |
58,83 |
EBITDA-Marge3 |
19,20 |
19,05 |
24,16 |
25,34 |
31,61 |
24,98 |
|
EBIT1,4 |
17,97 |
23,39 |
32,06 |
33,69 |
47,45 |
44,54 |
45,45 |
EBIT-Marge5 |
12,96 |
13,86 |
17,96 |
19,13 |
26,30 |
20,04 |
18,47 |
Jahresüberschuss1 |
15,12 |
16,89 |
22,48 |
23,11 |
34,66 |
29,75 |
26,77 |
Netto-Marge6 |
10,91 |
10,01 |
12,59 |
13,12 |
19,21 |
13,39 |
10,88 |
Cashflow1,7 |
26,83 |
21,21 |
40,43 |
36,79 |
33,86 |
34,30 |
47,40 |
Ergebnis je Aktie8 |
0,70 |
0,78 |
1,07 |
1,11 |
1,66 |
1,41 |
1,26 |
Dividende8 |
0,20 |
0,30 |
0,42 |
0,45 |
0,50 |
0,50 |
0,17 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2022 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Mazars
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Eckert & Ziegler |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
565970 |
36,500 |
Halten |
772,78 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
22,81 |
26,26 |
0,89 |
40,15 |
KBV |
KCV |
KUV |
EV/EBITDA |
3,49 |
16,30 |
3,14 |
12,62 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,50 |
0,05 |
0,14 |
28.05.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
14.05.2024 |
09.08.2024 |
14.11.2024 |
22.03.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
-7,67% |
-1,70% |
-11,62% |
-21,67% |
|
|